Moderna, Inc. (MRNA) Stock buybacks 2019–2025
Moderna, Inc. (MRNA) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$2.0MFY2025 · since FY2019: $0 → $2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.0M | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $1.2B | -65.4% |
| FY2022 | $3.3B | +288.4% |
| FY2021 | $857.0M | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA RevenueMRNA Net incomeMRNA Net marginMRNA Gross profitMRNA Gross marginMRNA Operating incomeMRNA Operating marginMRNA Operating cash flowMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Dividends paidMRNA Total assetsMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →